alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Official Journal C 265I/2023

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 265I |
| | |
| English edition | Information and Notices | Volume 6628 July 2023 |

ISSN 1977-091X

Official Journal

of the European Union

C 265I

English edition

Information and Notices

Volume 6628 July 2023

---

| Contents | page |
| --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | Council |
| 2023/C 265 I/01 | Notice for the attention of the persons and entities subject to the restrictive measures provided for in Council Decision 2014/145/CFSP, as amended by Council Decision (CFSP) 2023/1566, and Council Regulation (EU) No 269/2014, as implemented by Council Implementing Regulation (EU) 2023/1563 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine | 1 |
| 2023/C 265 I/02 | Notice for the attention of the persons and entities subject to the restrictive measures provided for in Council Decision 2014/145/CFSP, as amended by Council Decision (CFSP) 2023/1566, and Council Regulation (EU) No 269/2014 as implemented by Council Implementing Regulation (EU) 2023/1563 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine | 3 |
| 2023/C 265 I/03 | Notice for the attention of the data subjects to whom the restrictive measures provided for in Council Decision 2014/145/CFSP and Council Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine apply | 4 |

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

Council

2023/C 265 I/01

Notice for the attention of the persons and entities subject to the restrictive measures provided for in Council Decision 2014/145/CFSP, as amended by Council Decision (CFSP) 2023/1566, and Council Regulation (EU) No 269/2014, as implemented by Council Implementing Regulation (EU) 2023/1563 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine

1

2023/C 265 I/02

Notice for the attention of the persons and entities subject to the restrictive measures provided for in Council Decision 2014/145/CFSP, as amended by Council Decision (CFSP) 2023/1566, and Council Regulation (EU) No 269/2014 as implemented by Council Implementing Regulation (EU) 2023/1563 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine

3

2023/C 265 I/03

Notice for the attention of the data subjects to whom the restrictive measures provided for in Council Decision 2014/145/CFSP and Council Regulation (EU) No 269/2014 concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of Ukraine apply

4

---

| EN | |
| --- | --- |

EN
###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Part 3

#### Editorial Note:

Nomenclature changes to part 3 appear at 68 FR 14337, Mar. 25, 2003.

#### § 3.51 Recording date.

The date of recording of a document is the date the document meeting the requirements for recording set forth in this part is filed in the Office. A document which does not comply with the identification requirements of § 3.21 will not be recorded. Documents not meeting the other requirements for recording, for example, a document submitted without a completed cover sheet or without the required fee, will be returned for correction to the sender where a correspondence address is available. The returned papers, stamped with the original date of receipt by the Office, will be accompanied by a letter which will indicate that if the returned papers are corrected and resubmitted to the Office within the time specified in the letter, the Office will consider the original date of filing of the papers as the date of recording of the document. The procedure set forth in § 1.8 or § 1.10 of this chapter may be used for resubmissions of returned papers to have the benefit of the date of deposit in the United States Postal Service. If the returned papers are not corrected and resubmitted within the specified period, the date of filing of the corrected papers will be considered to be the date of recording of the document. The specified period to resubmit the returned papers will not be extended.

[62 FR 53203, Oct. 10, 1997]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
# Official Journal L 80I/2023

| | ISSN 1977-0677 |
| --- | --- |
| Official Journal
  of the European Union | L 080I |
| | |
| English edition | Legislation | Volume 6620 March 2023 |

ISSN 1977-0677

Official Journal

of the European Union

L 080I

English edition

Legislation

Volume 6620 March 2023

---

| Contents | | II   Non-legislative acts | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | * | Council Implementing Regulation (EU) 2023/645 of 20 March 2023 implementing Regulation (EU) No 359/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Iran | 1 |
| | | DECISIONS |
| | * | Council Implementing Decision (CFSP) 2023/646 of 20 March 2023 implementing Decision 2011/235/CFSP concerning restrictive measures directed against certain persons and entities in view of the situation in Iran | 7 |

Contents

II   Non-legislative acts

page

REGULATIONS

*

Council Implementing Regulation (EU) 2023/645 of 20 March 2023 implementing Regulation (EU) No 359/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Iran

1

DECISIONS

*

Council Implementing Decision (CFSP) 2023/646 of 20 March 2023 implementing Decision 2011/235/CFSP concerning restrictive measures directed against certain persons and entities in view of the situation in Iran

7

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
<TABLE> <S> <C>

<ARTICLE> 7
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                                    9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               SEP-30-1998
<EXCHANGE-RATE>                                      1
<DEBT-HELD-FOR-SALE>                           232,042
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                       5,216
<MORTGAGE>                                           0
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                                 255,714
<CASH>                                           1,974
<RECOVER-REINSURE>                             170,838
<DEFERRED-ACQUISITION>                           4,660
<TOTAL-ASSETS>                                 542,298
<POLICY-LOSSES>                                299,174
<UNEARNED-PREMIUMS>                             53,096
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                 23,428
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           843
<OTHER-SE>                                     141,429
<TOTAL-LIABILITY-AND-EQUITY>                   542,298
<PREMIUMS>                                      53,452
<INVESTMENT-INCOME>                             11,394
<INVESTMENT-GAINS>                               1,405
<OTHER-INCOME>                                     720
<BENEFITS>                                      31,040
<UNDERWRITING-AMORTIZATION>                      8,908
<UNDERWRITING-OTHER>                            16,873
<INCOME-PRETAX>                                 12,731
<INCOME-TAX>                                     3,340
<INCOME-CONTINUING>                              9,391
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     9,391
<EPS-PRIMARY>                                     1.12
<EPS-DILUTED>                                     1.11
<RESERVE-OPEN>                                 139,841
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                132,387
<CUMULATIVE-DEFICIENCY>                              0
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 7
<MULTIPLIER> 1,000
<CURRENCY> US DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<EXCHANGE-RATE>                                      1
<DEBT-HELD-FOR-SALE>                           216,186
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                      10,975
<MORTGAGE>                                           0
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                                 239,173
<CASH>                                           1,656
<RECOVER-REINSURE>                             132,289
<DEFERRED-ACQUISITION>                           3,867
<TOTAL-ASSETS>                                 445,747
<POLICY-LOSSES>                                258,838
<UNEARNED-PREMIUMS>                             33,720
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                 17,942
<COMMON>                                           828
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                     116,584
<TOTAL-LIABILITY-AND-EQUITY>                   445,747
<PREMIUMS>                                      18,406
<INVESTMENT-INCOME>                              3,371
<INVESTMENT-GAINS>                                 212
<OTHER-INCOME>                                   1,829
<BENEFITS>                                      10,846
<UNDERWRITING-AMORTIZATION>                      3,140
<UNDERWRITING-OTHER>                             5,351
<INCOME-PRETAX>                                  4,194
<INCOME-TAX>                                       959
<INCOME-CONTINUING>                              3,235
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,235
<EPS-PRIMARY>                                     0.39
<EPS-DILUTED>                                     0.39
<RESERVE-OPEN>                                 132,558
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                130,967
<CUMULATIVE-DEFICIENCY>                              0
        

</TABLE>
EXHIBIT 32.1
                   CERTIFICATION PURSUANT TO
                    18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
         SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



     In connection with the Quarterly Report of Research Frontiers
Incorporated (the "Company") on Form 10-Q for the quarter ended
June 30, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Robert L. Saxe,
Chairman of the Board and Chief Technology Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.   The Report fully complies with the requirements of Section
     13(a) or 15(d), as applicable, of the Securities Exchange Act
     of 1934; and

2.   The information contained in the Report fairly presents, in all
     material respects, the financial condition and results of
     operations of the Company.


/s/ Robert L. Saxe
    Robert L. Saxe
    Chairman of the Board and Chief Technology Officer

Date: August 5, 2010
#### §§ 39.64-39.79 [Reserved]
**EXHIBIT 11-1**

 

 

THE NAVIGATORS GROUP, INC. AND SUBSIDIARIES

 

 

COMPUTATION OF PER SHARE EARNINGS

 

Earnings Per Share of Common Stock and Common Stock Equivalents

 

*($ in thousands,except per share data)*

 

 
|                                                                      |   | **Three  Month Ended  March 31,** |   |
|---------------------------------------------------------------------------|--------|-----------------------------------|--------|
|                                                                      |   | **2004**                          |   | **2003** |   |
|                                                                      |   |                              |   |   |   |
| Net income applicable to common stock                                     |   | $                                 | 8,913  |   | $ | 4,710 |   |
|                                                                      |   |                              |   |   |   |
| Average number of common shares outstanding                               |   | 12,554                            |   | 8,494 |   |
|                                                                      |   |                              |   |   |   |
| Net income per share – Basic                                         |   | $                                 | 0.71   |   | $ | 0.55 |   |
|                                                                      |   |                              |   |   |   |
| Average number of common shares outstanding                               |   | 12,554                            |   | 8,494 |   |
| Add:   Assumed exercise of stock options and vesting of stock grants |   | 100                               |   | 230 |   |
|                                                                      |   |                              |   |   |   |
| Common and common equivalent shares  outstanding                          |   | 12,654                            |   | 8,724 |   |
|                                                                      |   |                              |   |   |   |
| Net income per share – Diluted                                       |   | $                                 | 0.70   |   | $ | 0.54 |   |

 

1

----
#### § 23.120 Transfers of property.

If a recipient sells or otherwise transfers property financed in whole or in part with Federal financial assistance to a transferee that operates any education program or activity, and the Federal share of the fair market value of the property is not upon such sale or transfer properly accounted for to the Federal Government, both the transferor and the transferee shall be deemed to be recipients, subject to the provisions of §§ 23.205 through 23.235(a).
# United States Court **of Appeals**  **f or the Fifth Circuit** 

No. 20

- 50624 Conference Calendar

**United States of America,**

Plaintiff

— Appellee **,**

versus

**Roxanne Ojeda,**

Defendant

— Appellant

**.**

Appeal from the United States District Court for the Western District of Texas USDC No. 4:14

- CR

- 628

- 11

Before **Davis, Elrod,** and **Oldham,** Circuit Judges

**. Per Curiam**  **:** *

The Federal Public Defender appointed to represent Roxanne Ojeda
has moved for leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Ojeda has not filed a response. We have reviewed

* Pursuant to **5th Cir cuit**  **R ule**  47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in **5th Cir cuit**  **R ule**  47.5.4. United States Court of Appeals Fifth Circuit 

### FILED June 30, 2021
Lyle W. Cayce Clerk Case: 20-50624 Document: 00515919875 Page: 1 Date Filed: 06/30/2021No. 20

- 50624

2 counsel’s brief and the relevant portions of the record reflected therein. We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellat e review. Accordingly, counsel’s motion for leave to
withdraw is **GRANTED** , counsel is excused from further responsibilities herein, and the **APPEAL IS DISMISSED**

. See **5th Cir. R.** 42.2

. Case: 20-50624 Document: 00515919875 Page: 2 Date Filed: 06/30/2021
Editorial Note on Part 3
Editorial Note: Nomenclature changes to part 3 appear at 61 FR 7216, Feb. 27, 1996; 62 FR 35970, July 3, 1997; 62 FR 47532, Sept. 9, 1997; and 67 FR 46868, July 17, 2002.

§ 3.328 lndependent medical opinions. ( a ) *General.* When warranted by the medical complexity or controversy involved in a pending claim, an advisory medical opinion may be obtained from one or more medical experts who are not employees of VA. Opinions shall be obtained from recognized medical schools, universities, clinics or medical institutions with which arrangements for such opinions have been made, and an appropriate official of the institution shall select the individual expert(s) to render an opinion.
( b ) *Requests.* A request for an independent medical opinion in conjunction with a claim pending before VA may be initiated by the office having jurisdiction over the claim, by the claimant, or by his or her duly appointed representative. The request must be submitted in writing and must set forth in detail the reasons why the opinion is necessary. All such requests shall be submitted through the Veterans Service Center Manager or Pension Management Center Manager of the office having jurisdiction over the claim, and those requests which in the judgment of the Veterans Service Center Manager or Pension Management Center Manager merit consideration shall be referred to the Compensation Service or the Pension and Fiduciary Service for approval.
( c ) *Approval.* ( 1 ) Requests for independent medical opinions shall be approved when one of the following conditions is met: ( i ) The director of each Service from which a benefit is sought, or his or her designee, determines that the issue under consideration poses a medical problem of such complexity or controversy as to justify solicitation of an independent medical opinion; or
( ii ) The independent medical opinion is required to fulfill the instructions contained in a remand order from the Board of Veterans' Appeals.
( 2 ) A determination that an independent medical opinion is not warranted may be contested only as part of an appeal to the Board of Veterans' Appeals on the merits of the decision rendered on the primary issue by VA.
( d ) *Notification.* The Compensation Service or the Pension and Fiduciary Service shall notify the claimant when the request for an independent medical opinion has been approved with regard to his or her claim and shall furnish the claimant with a copy of the opinion when it is received. If, in the judgment of the Secretary, disclosure of the independent medical opinion would be harmful to the physical or mental health of the claimant, disclosure shall be subject to the special procedures set forth in § 1.577 of this chapter.
(Authority: 38 U.S.C. 5109, 5701(b)(1); 5 U.S.C. 552a(f)(3))
[55 FR 18602, May 3, 1990, as amended at 79 FR 2100, Jan. 13, 2014; 84 FR 170, Jan. 18, 2019]
Exhibit 32

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Cogenco International, Inc. (the
"Company") on Form 10-QSB for the period ended December 31, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
David W. Brenman, President, certify, pursuant to 18 U.S.C. ss. 1350, as adopted
pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

     (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


Date: November 14, 2005                 /s/ David W. Brenman
                                       -----------------------------------------
                                       David W. Brenman, President
                                       Principal Executive Officer,
                                       Principal Accounting Officer,
                                       Principal Financial Officer and Director